Skip to main content
Top
Published in: Cardiovascular Diabetology 1/2015

Open Access 01-12-2015 | Original investigation

Association between blood glucose variability and coronary plaque instability in patients with acute coronary syndromes

Authors: Kozo Okada, Kiyoshi Hibi, Masaomi Gohbara, Shunsuke Kataoka, Keiko Takano, Eiichi Akiyama, Yasushi Matsuzawa, Kenichiro Saka, Nobuhiko Maejima, Mitsuaki Endo, Noriaki Iwahashi, Kengo Tsukahara, Masami Kosuge, Toshiaki Ebina, Peter J. Fitzgerald, Yasuhiro Honda, Satoshi Umemura, Kazuo Kimura

Published in: Cardiovascular Diabetology | Issue 1/2015

Login to get access

Abstract

Background

Blood glucose variability is receiving considerable attention as a new risk factor for coronary artery disease. This study aimed to investigate the association between blood glucose variability and coronary plaque tissue characteristics.

Methods

In 57 patients with acute coronary syndrome, integrated backscatter intravascular ultrasound (IB-IVUS) and gray-scale IVUS were performed before balloon dilatation or stent implantation in the culprit vessels. Standard IVUS indices were evaluated for volume index (volume/length), and plaque components were measured by IB-IVUS for percent tissue volume. In addition to conventional glucose indicators, blood glucose variability in a stable state was determined by calculating the mean amplitude of glycemic excursions (MAGE) using a continuous glucose monitoring system.

Results

Higher MAGE values were significantly correlated with larger percent plaque volumes (r = 0.32, p = 0.015), and increased lipid (r = 0.44, p = 0.0006) and decreased fibrous (r = −0.45, p = 0.0005) plaque components. In contrast, HbA1c or fasting plasma glucose values were not significantly correlated with plaque volumes and percent plaque components. Homeostasis model assessment of insulin resistance values were positively correlated with vessel (r = 0.35, p = 0.007) and plaque (r = 0.27, p = 0.046) volumes, but not with percent plaque components. In multiple regression analysis, higher MAGE values were independently associated with increased lipid (β = 0.80, p = 0.0035) and decreased fibrous (β = -0.79, p = 0.0034) contents in coronary plaques.

Conclusions

Among all glucose indicators studied, only higher blood glucose variability was an independent determinant of increased lipid and decreased fibrous contents with larger plaque burden, suggesting blood glucose variability as one of the important factors related to coronary plaque vulnerability.
Literature
1.
go back to reference Stratton IM, Adler AI, Neil HA, Matthews DR, Manley SE, Cull CA et al (2000) Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ 321:405–412PubMedCentralCrossRefPubMed Stratton IM, Adler AI, Neil HA, Matthews DR, Manley SE, Cull CA et al (2000) Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ 321:405–412PubMedCentralCrossRefPubMed
2.
go back to reference Amano T, Matsubara T, Uetani T, Nanki M, Marui N, Kato M et al (2008) Abnormal glucose regulation is associated with lipid-rich coronary plaque: relationship to insulin resistance. JACC Cardiovasc Imaging 1:39–45CrossRefPubMed Amano T, Matsubara T, Uetani T, Nanki M, Marui N, Kato M et al (2008) Abnormal glucose regulation is associated with lipid-rich coronary plaque: relationship to insulin resistance. JACC Cardiovasc Imaging 1:39–45CrossRefPubMed
3.
go back to reference Inaba S, Okayama H, Funada J-I, Higashi H, Saito M, Yoshii T et al (2012) Impact of type 2 diabetes on serial changes in tissue characteristics of coronary plaques: an integrated backscatter intravascular ultrasound analysis. Eur Heart J Cardiovasc Imaging 13:717–723CrossRefPubMed Inaba S, Okayama H, Funada J-I, Higashi H, Saito M, Yoshii T et al (2012) Impact of type 2 diabetes on serial changes in tissue characteristics of coronary plaques: an integrated backscatter intravascular ultrasound analysis. Eur Heart J Cardiovasc Imaging 13:717–723CrossRefPubMed
4.
go back to reference Fukushima Y, Daida H, Morimoto T, Kasai T, Miyauchi K, Yamagishi S-I et al (2013) Relationship between advanced glycation end products and plaque progression in patients with acute coronary syndrome: the JAPAN-ACS sub-study. Cardiovasc Diabetol 12:5PubMedCentralCrossRefPubMed Fukushima Y, Daida H, Morimoto T, Kasai T, Miyauchi K, Yamagishi S-I et al (2013) Relationship between advanced glycation end products and plaque progression in patients with acute coronary syndrome: the JAPAN-ACS sub-study. Cardiovasc Diabetol 12:5PubMedCentralCrossRefPubMed
5.
go back to reference Piotrowski K, Becker M, Zugwurst J, Biller-Friedmann I, Spoettl G, Greif M et al (2013) Circulating concentrations of GLP-1 are associated with coronary atherosclerosis in humans. Cardiovasc Diabetol 12:117PubMedCentralCrossRefPubMed Piotrowski K, Becker M, Zugwurst J, Biller-Friedmann I, Spoettl G, Greif M et al (2013) Circulating concentrations of GLP-1 are associated with coronary atherosclerosis in humans. Cardiovasc Diabetol 12:117PubMedCentralCrossRefPubMed
6.
go back to reference Mitsuhashi T, Hibi K, Kosuge M, Morita S, Komura N, Kusama I et al (2011) Relation between hyperinsulinemia and nonculprit plaque characteristics in nondiabetic patients with acute coronary syndromes. JACC Cardiovasc Imaging 4:392–401CrossRefPubMed Mitsuhashi T, Hibi K, Kosuge M, Morita S, Komura N, Kusama I et al (2011) Relation between hyperinsulinemia and nonculprit plaque characteristics in nondiabetic patients with acute coronary syndromes. JACC Cardiovasc Imaging 4:392–401CrossRefPubMed
7.
go back to reference Yang DJ, Lee M-S, Kim WH, Park HW, Kim K-H, Kwon T-G et al (2013) The impact of glucose control on coronary plaque composition in patients with diabetes mellitus. J Invasive Cardiol 25:137–141PubMed Yang DJ, Lee M-S, Kim WH, Park HW, Kim K-H, Kwon T-G et al (2013) The impact of glucose control on coronary plaque composition in patients with diabetes mellitus. J Invasive Cardiol 25:137–141PubMed
8.
go back to reference Rizzo MR, Barbieri M, Marfella R, Paolisso G (2012) Reduction of oxidative stress and inflammation by blunting daily acute glucose fluctuations in patients with type 2 diabetes: role of dipeptidyl peptidase-IV inhibition. Diabetes Care 35:2076–2082PubMedCentralCrossRefPubMed Rizzo MR, Barbieri M, Marfella R, Paolisso G (2012) Reduction of oxidative stress and inflammation by blunting daily acute glucose fluctuations in patients with type 2 diabetes: role of dipeptidyl peptidase-IV inhibition. Diabetes Care 35:2076–2082PubMedCentralCrossRefPubMed
9.
go back to reference Torimoto K, Okada Y, Mori H, Tanaka Y (2013) Relationship between fluctuations in glucose levels measured by continuous glucose monitoring and vascular endothelial dysfunction in type 2 diabetes mellitus. Cardiovasc Diabetol 12:1PubMedCentralCrossRefPubMed Torimoto K, Okada Y, Mori H, Tanaka Y (2013) Relationship between fluctuations in glucose levels measured by continuous glucose monitoring and vascular endothelial dysfunction in type 2 diabetes mellitus. Cardiovasc Diabetol 12:1PubMedCentralCrossRefPubMed
10.
go back to reference Kuroda M, Shinke T, Sakaguchi K, Otake H, Takaya T, Hirota Y et al (2015) Effect of daily glucose fluctuation on coronary plaque vulnerability in patients pre-treated with lipid-lowering therapy: a prospective observational study. JACC Cardiovasc Interv 8:800–811CrossRefPubMed Kuroda M, Shinke T, Sakaguchi K, Otake H, Takaya T, Hirota Y et al (2015) Effect of daily glucose fluctuation on coronary plaque vulnerability in patients pre-treated with lipid-lowering therapy: a prospective observational study. JACC Cardiovasc Interv 8:800–811CrossRefPubMed
11.
go back to reference Tylee TS, Trence DL (2012) Glycemic variability: looking beyond the A1C. Diabetes Spectr 25:149–153CrossRef Tylee TS, Trence DL (2012) Glycemic variability: looking beyond the A1C. Diabetes Spectr 25:149–153CrossRef
12.
go back to reference Monnier L, Mas E, Ginet C, Michel F, Villon L, Cristol J-P et al (2006) Activation of oxidative stress by acute glucose fluctuations compared with sustained chronic hyperglycemia in patients with type 2 diabetes. JAMA 295:1681–1687CrossRefPubMed Monnier L, Mas E, Ginet C, Michel F, Villon L, Cristol J-P et al (2006) Activation of oxidative stress by acute glucose fluctuations compared with sustained chronic hyperglycemia in patients with type 2 diabetes. JAMA 295:1681–1687CrossRefPubMed
13.
go back to reference Teraguchi I, Imanishi T, Ozaki Y, Tanimoto T, Orii M, Shiono Y et al (2014) Impact of glucose fluctuation and monocyte subsets on coronary plaque rupture. Nutr Metab Cardiovasc Dis 24:309–314CrossRefPubMed Teraguchi I, Imanishi T, Ozaki Y, Tanimoto T, Orii M, Shiono Y et al (2014) Impact of glucose fluctuation and monocyte subsets on coronary plaque rupture. Nutr Metab Cardiovasc Dis 24:309–314CrossRefPubMed
14.
go back to reference Task Force on the management of ST-segment elevation acute myocardial infarction of the European Society of Cardiology (ESC), Steg PG, James SK, Atar D, Badano LP, Blömstrom-Lundqvist C et al (2012) ESC guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. Eur Heart J 33:2569–2619CrossRef Task Force on the management of ST-segment elevation acute myocardial infarction of the European Society of Cardiology (ESC), Steg PG, James SK, Atar D, Badano LP, Blömstrom-Lundqvist C et al (2012) ESC guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. Eur Heart J 33:2569–2619CrossRef
15.
go back to reference Bergenstal RM, Ahmann AJ, Bailey T, Beck RW, Bissen J, Buckingham B et al (2013) Recommendations for standardizing glucose reporting and analysis to optimize clinical decision making in diabetes: the ambulatory glucose profile (AGP). Diabetes Technol Ther 15(3):198–211. doi:10.1089/dia.2013.0051 CrossRefPubMed Bergenstal RM, Ahmann AJ, Bailey T, Beck RW, Bissen J, Buckingham B et al (2013) Recommendations for standardizing glucose reporting and analysis to optimize clinical decision making in diabetes: the ambulatory glucose profile (AGP). Diabetes Technol Ther 15(3):198–211. doi:10.​1089/​dia.​2013.​0051 CrossRefPubMed
16.
go back to reference Nakamura T, Sugaya T, Kawagoe Y, Ueda Y, Osada S, Koide H (2005) Effect of pitavastatin on urinary liver-type fatty acid-binding protein levels in patients with early diabetic nephropathy. Diabetes Care 28:2728–2732CrossRefPubMed Nakamura T, Sugaya T, Kawagoe Y, Ueda Y, Osada S, Koide H (2005) Effect of pitavastatin on urinary liver-type fatty acid-binding protein levels in patients with early diabetic nephropathy. Diabetes Care 28:2728–2732CrossRefPubMed
18.
go back to reference Nakayama N, Hibi K, Endo M, Miyazawa A, Suzuki H, Maejima N et al (2013) Validity and reliability of new intravascular ultrasound analysis software for morphological measurement of coronary artery disease. Circ J 77:424–431CrossRefPubMed Nakayama N, Hibi K, Endo M, Miyazawa A, Suzuki H, Maejima N et al (2013) Validity and reliability of new intravascular ultrasound analysis software for morphological measurement of coronary artery disease. Circ J 77:424–431CrossRefPubMed
19.
go back to reference Mintz GS, Nissen SE, Anderson WD, Bailey SR, Erbel R, Fitzgerald PJ et al (2001) American College of Cardiology clinical expert consensus document on standards for acquisition, measurement and reporting of intravascular ultrasound studies (IVUS): a report of the American College of Cardiology Task Force on clinical expert consensus documents. J Am Coll Cardiol 37:1478–1492CrossRefPubMed Mintz GS, Nissen SE, Anderson WD, Bailey SR, Erbel R, Fitzgerald PJ et al (2001) American College of Cardiology clinical expert consensus document on standards for acquisition, measurement and reporting of intravascular ultrasound studies (IVUS): a report of the American College of Cardiology Task Force on clinical expert consensus documents. J Am Coll Cardiol 37:1478–1492CrossRefPubMed
20.
go back to reference Fuster V, Badimon L, Badimon JJ, Chesebro JH (1992) The pathogenesis of coronary artery disease and the acute coronary syndromes (1). N Engl J Med 326:242–250CrossRefPubMed Fuster V, Badimon L, Badimon JJ, Chesebro JH (1992) The pathogenesis of coronary artery disease and the acute coronary syndromes (1). N Engl J Med 326:242–250CrossRefPubMed
21.
go back to reference Kawasaki M, Takatsu H, Noda T, Sano K, Ito Y, Hayakawa K, Tsuchiya K et al (2002) In vivo quantitative tissue characterization of human coronary arterial plaques by use of integrated backscatter intravascular ultrasound and comparison with angioscopic findings. Circulation 105:2487–2492CrossRefPubMed Kawasaki M, Takatsu H, Noda T, Sano K, Ito Y, Hayakawa K, Tsuchiya K et al (2002) In vivo quantitative tissue characterization of human coronary arterial plaques by use of integrated backscatter intravascular ultrasound and comparison with angioscopic findings. Circulation 105:2487–2492CrossRefPubMed
22.
go back to reference Sano K, Kawasaki M, Ishihara Y, Okubo M, Tsuchiya K, Nishigaki K et al (2006) Assessment of vulnerable plaques causing acute coronary syndrome using integrated backscatter intravascular ultrasound. J Am Coll Cardiol 47:734–741CrossRefPubMed Sano K, Kawasaki M, Ishihara Y, Okubo M, Tsuchiya K, Nishigaki K et al (2006) Assessment of vulnerable plaques causing acute coronary syndrome using integrated backscatter intravascular ultrasound. J Am Coll Cardiol 47:734–741CrossRefPubMed
23.
go back to reference Miyamoto Y, Okura H, Kume T, Kawamoto T, Neishi Y, Hayashida A et al (2011) Plaque characteristics of thin-cap fibroatheroma evaluated by OCT and IVUS. JACC Cardiovasc Imaging 4:638–646CrossRefPubMed Miyamoto Y, Okura H, Kume T, Kawamoto T, Neishi Y, Hayashida A et al (2011) Plaque characteristics of thin-cap fibroatheroma evaluated by OCT and IVUS. JACC Cardiovasc Imaging 4:638–646CrossRefPubMed
24.
go back to reference Ceriello A, Esposito K, Piconi L, Ihnat MA, Thorpe JE, Testa R et al (2008) Oscillating glucose is more deleterious to endothelial function and oxidative stress than mean glucose in normal and type 2 diabetic patients. Diabetes 57:1349–1354CrossRefPubMed Ceriello A, Esposito K, Piconi L, Ihnat MA, Thorpe JE, Testa R et al (2008) Oscillating glucose is more deleterious to endothelial function and oxidative stress than mean glucose in normal and type 2 diabetic patients. Diabetes 57:1349–1354CrossRefPubMed
25.
go back to reference Griendling KK, FitzGerald GA (2003) Oxidative stress and cardiovascular injury: part I: basic mechanisms and in vivo monitoring of ROS. Circulation 108:1912–1916CrossRefPubMed Griendling KK, FitzGerald GA (2003) Oxidative stress and cardiovascular injury: part I: basic mechanisms and in vivo monitoring of ROS. Circulation 108:1912–1916CrossRefPubMed
26.
go back to reference Griendling KK, FitzGerald GA (2003) Oxidative stress and cardiovascular injury: part II: animal and human studies. Circulation 108:2034–2040CrossRefPubMed Griendling KK, FitzGerald GA (2003) Oxidative stress and cardiovascular injury: part II: animal and human studies. Circulation 108:2034–2040CrossRefPubMed
27.
go back to reference Salvayre R, Auge N, Benoist H, Negre-Salvayre A (2002) Oxidized low-density lipoprotein-induced apoptosis. Biochim Biophys Acta 1585:213–221CrossRefPubMed Salvayre R, Auge N, Benoist H, Negre-Salvayre A (2002) Oxidized low-density lipoprotein-induced apoptosis. Biochim Biophys Acta 1585:213–221CrossRefPubMed
28.
go back to reference Sano T, Tanaka A, Namba M, Nishibori Y, Nishida Y, Kawarabayashi T et al (2003) C-reactive protein and lesion morphology in patients with acute myocardial infarction. Circulation 108:282–285CrossRefPubMed Sano T, Tanaka A, Namba M, Nishibori Y, Nishida Y, Kawarabayashi T et al (2003) C-reactive protein and lesion morphology in patients with acute myocardial infarction. Circulation 108:282–285CrossRefPubMed
29.
go back to reference Choi B-J, Prasad A, Gulati R, Best PJ, Lennon RJ, Barsness GW et al (2013) Coronary endothelial dysfunction in patients with early coronary artery disease is associated with the increase in intravascular lipid core plaque. Eur Heart J 34:2047–2054PubMedCentralCrossRefPubMed Choi B-J, Prasad A, Gulati R, Best PJ, Lennon RJ, Barsness GW et al (2013) Coronary endothelial dysfunction in patients with early coronary artery disease is associated with the increase in intravascular lipid core plaque. Eur Heart J 34:2047–2054PubMedCentralCrossRefPubMed
30.
go back to reference Asakura M, Ueda Y, Yamaguchi O, Adachi T, Hirayama A, Hori M et al (2001) Extensive development of vulnerable plaques as a pan-coronary process in patients with myocardial infarction: an angioscopic study. J Am Coll Cardiol 37:1284–1288CrossRefPubMed Asakura M, Ueda Y, Yamaguchi O, Adachi T, Hirayama A, Hori M et al (2001) Extensive development of vulnerable plaques as a pan-coronary process in patients with myocardial infarction: an angioscopic study. J Am Coll Cardiol 37:1284–1288CrossRefPubMed
31.
go back to reference Monnier L, Lapinski H, Colette C (2003) Contributions of fasting and postprandial plasma glucose increments to the overall diurnal hyperglycemia of type 2 diabetic patients: variations with increasing levels of HbA(1c). Diabetes Care 26:881–885CrossRefPubMed Monnier L, Lapinski H, Colette C (2003) Contributions of fasting and postprandial plasma glucose increments to the overall diurnal hyperglycemia of type 2 diabetic patients: variations with increasing levels of HbA(1c). Diabetes Care 26:881–885CrossRefPubMed
32.
go back to reference Sartore G, Chilelli NC, Burlina S, Di Stefano P, Piarulli F, Fedele D et al (2012) The importance of HbA1c and glucose variability in patients with type 1 and type 2 diabetes: outcome of continuous glucose monitoring (CGM). Acta Diabetol 49(Suppl 1):S153–S160CrossRefPubMed Sartore G, Chilelli NC, Burlina S, Di Stefano P, Piarulli F, Fedele D et al (2012) The importance of HbA1c and glucose variability in patients with type 1 and type 2 diabetes: outcome of continuous glucose monitoring (CGM). Acta Diabetol 49(Suppl 1):S153–S160CrossRefPubMed
33.
go back to reference DECODE Study Group, The European Diabetes Epidemiology Group (2001) Glucose tolerance and cardiovascular mortality: comparison of fasting and 2-hour diagnostic criteria. Arch Intern Med 161:397–405CrossRef DECODE Study Group, The European Diabetes Epidemiology Group (2001) Glucose tolerance and cardiovascular mortality: comparison of fasting and 2-hour diagnostic criteria. Arch Intern Med 161:397–405CrossRef
34.
go back to reference Hanefeld M, Duetting E, Bramlage P (2013) Cardiac implications of hypoglycaemia in patients with diabetes—a systematic review. Cardiovasc Diabetol 12:135PubMedCentralCrossRefPubMed Hanefeld M, Duetting E, Bramlage P (2013) Cardiac implications of hypoglycaemia in patients with diabetes—a systematic review. Cardiovasc Diabetol 12:135PubMedCentralCrossRefPubMed
35.
go back to reference Kang ES, Yun YS, Park SW, Kim HJ, Ahn CW, Song YD et al (2005) Limitation of the validity of the homeostasis model assessment as an index of insulin resistance in Korea. Metab Clin Exp 54:206–211CrossRefPubMed Kang ES, Yun YS, Park SW, Kim HJ, Ahn CW, Song YD et al (2005) Limitation of the validity of the homeostasis model assessment as an index of insulin resistance in Korea. Metab Clin Exp 54:206–211CrossRefPubMed
36.
go back to reference Kojima S, Kojima S, Maruyoshi H, Nagayoshi Y, Kaikita K, Sumida H et al (2011) Hypercholesterolemia and hypoadiponectinemia are associated with necrotic core-rich coronary plaque. Int J Cardiol 147:371–376CrossRefPubMed Kojima S, Kojima S, Maruyoshi H, Nagayoshi Y, Kaikita K, Sumida H et al (2011) Hypercholesterolemia and hypoadiponectinemia are associated with necrotic core-rich coronary plaque. Int J Cardiol 147:371–376CrossRefPubMed
37.
go back to reference Hirano T, Ito Y, Koba S, Toyoda M, Ikejiri A, Saegusa H et al (2004) Clinical significance of small dense low-density lipoprotein cholesterol levels determined by the simple precipitation method. Arterioscler Thromb Vasc Biol 24:558–563CrossRefPubMed Hirano T, Ito Y, Koba S, Toyoda M, Ikejiri A, Saegusa H et al (2004) Clinical significance of small dense low-density lipoprotein cholesterol levels determined by the simple precipitation method. Arterioscler Thromb Vasc Biol 24:558–563CrossRefPubMed
38.
go back to reference St-Pierre AC, Cantin B, Dagenais GR, Mauriège P, Bernard P-M, Després J-P et al (2005) Low-density lipoprotein subfractions and the long-term risk of ischemic heart disease in men: 13-year follow-up data from the Québec Cardiovascular Study. Arterioscler Thromb Vasc Biol 25:553–559CrossRefPubMed St-Pierre AC, Cantin B, Dagenais GR, Mauriège P, Bernard P-M, Després J-P et al (2005) Low-density lipoprotein subfractions and the long-term risk of ischemic heart disease in men: 13-year follow-up data from the Québec Cardiovascular Study. Arterioscler Thromb Vasc Biol 25:553–559CrossRefPubMed
Metadata
Title
Association between blood glucose variability and coronary plaque instability in patients with acute coronary syndromes
Authors
Kozo Okada
Kiyoshi Hibi
Masaomi Gohbara
Shunsuke Kataoka
Keiko Takano
Eiichi Akiyama
Yasushi Matsuzawa
Kenichiro Saka
Nobuhiko Maejima
Mitsuaki Endo
Noriaki Iwahashi
Kengo Tsukahara
Masami Kosuge
Toshiaki Ebina
Peter J. Fitzgerald
Yasuhiro Honda
Satoshi Umemura
Kazuo Kimura
Publication date
01-12-2015
Publisher
BioMed Central
Published in
Cardiovascular Diabetology / Issue 1/2015
Electronic ISSN: 1475-2840
DOI
https://doi.org/10.1186/s12933-015-0275-3

Other articles of this Issue 1/2015

Cardiovascular Diabetology 1/2015 Go to the issue